News Center

New Biochip Holds Great Promise for Quickly Triaging People After Radiation Exposure

Berkeley Lab scientists have helped to develop a tiny chip that has big potential for quickly determining whether someone has been exposed to dangerous levels of ionizing radiation. The first-of-its-kind chip has an array of nanosensors that measure the concentrations of proteins that change after radiation exposure.

Secondhand Smoke in Bars and Restaurants Means Higher Risk of Asthma and Cancer

In the first study to evaluate the health risks of exposure to secondhand smoke for patrons of restaurants and bars, researchers have found that the risks are well above the acceptable level. The study assessed the risk for lung cancer and heart disease deaths among both patrons and servers and also for asthma initiation—the first study to do so—among servers.

Berkeley Lab Confirms Thirdhand Smoke Causes DNA Damage

A study led by researchers from Lawrence Berkeley National Laboratory has found for the first time that thirdhand smoke—the noxious residue that clings to virtually all surfaces long after the secondhand smoke from a cigarette has cleared out—causes significant genetic damage in human cells.

Berkeley Lab Researchers Discover How and Where Breast Tumor Cells Become Dormant and What Causes Them to Become Metastatic

Berkeley Lab researchers have identified the microenvironment surrounding microvasculature as a niche where dormant breast cancer cells may reside, and the sprouting of microvasculature blood vessels as the event that transforms dormant cancer cells into metastatic tumors.

Copper on the Brain

Berkeley Lab researchers have developed unique fluorescent probes for molecular imaging of copper in the brain, and are using these probes to uncover new information critical to a healthy mind.

Berkeley Lab Researchers Find New Clue to Clinical Trial Failures of MMP Cancer Therapies

Failure of Highly Touted MMP Cancer Therapies May Be Explained

New Details on the Molecular Machinery of Cancer

New details into the activation of a cell surface protein that has been strongly linked to a large number of cancers and is a major target of cancer therapies have been reported by Berkeley Lab researchers.

Genome-wide Atlas of Gene Enhancers in the Brain On-line

Berkeley Lab researchers have unveiled a first-of-its-kind atlas of gene-enhancers in the brain that should greatly benefit future research into the underlying causes of neurological disorders such as autism, epilepsy and schizophrenia.

Berkeley Lab Scientists Create First 3-D Model of a Protein Critical to Embryo Development

Berkeley Lab researchers have constructed the first detailed and complete picture of a protein complex that is tied to human birth defects as well as the progression of many forms of cancer. Knowing the architecture of this protein, PRC2, should be a boon to its future use in the development of new and improved therapeutic drugs.

Protein Linked to Therapy Resistance in Breast Cancer

Berkeley Lab researchers have identified the FAM83A protein as a possible new oncogene and linked it to therapy resistance in breast cancer. This discovery helps explain the clinical correlation between a high expression of FAM83A and a poor prognosis for breast cancer patients, and may also provide a new target for future therapies.